Picture of Zoono logo

ZNO — Zoono News Story

0.000.00%
au flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapFalling Star

Development And Licence Agreement With Douglas Pharmaceuticals

Oct 17 (Reuters) - Zoono Group Ltd  ZNO.AX :
    * ENTERS INTO CO-DEVELOPMENT AND LICENCE AGREEMENT WITH
DOUGLAS
PHARMACEUTICALS
    * IN DEAL PATIES AGREED TO GRANT LICENCE TO ITS 'BACKGROUND
IP' TO
ENABLE PARTIES TO JOINTLY DEVELOP SPECIALTY PRODUCTS FOR SALE

Source text for Eikon:  ID:nASX75m2Vy 
Further company coverage:  ZNO.AX 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zoono

See all news